Fast Track Initiative, Inc. logo

Fast Track Initiative, Inc.

Asia, Tokyo, Japan, Hongo

Description

Fast Track Initiative is a venture capital firm in Japan and the US with an exclusive focus on life sciences and healthcare.

Investor Profile

Fast Track Initiative, Inc. has backed more than 11 startups, with 2 new investments in the last 12 months alone. The firm has led 3 rounds, about 27% of its total and boasts 8 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in Japan, United States, United Kingdom.
  • Strong thematic focus on Health Care, Biotechnology, Medical.
  • Led 1 rounds in the past year.

Stage Focus

  • Series B (36%)
  • Series A (27%)
  • Series Unknown (18%)
  • Series C (9%)
  • Seed (9%)

Country Focus

  • Japan (64%)
  • United States (27%)
  • United Kingdom (9%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Nursing And Residential Care
  • Alternative Medicine
  • Clinical Trials
  • Pharmaceutical
  • Beauty
  • Education
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fast Track Initiative, Inc. frequently co-invest with?

UTokyo Innovation Platform
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
KRASYS
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Amgen Ventures
North America, California, United States, San Francisco
Co-Investments: 1
SMBC Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
S-Pool
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Mizuho Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Keio Innovation Initiative
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Aflac Global Ventures
North America, Georgia, United States, Columbus
Co-Investments: 1
Mitsubishi UFJ Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2

Which angels does Fast Track Initiative, Inc. often collaborate with?

Shared Deals: 1

What are some of recent deals done by Fast Track Initiative, Inc.?

Ichirou

Tokyo, Tokyo, Japan

Ichirou provides digital senior care support services that connect elderly people with caretakers.

Elder CareElderlyHealth CareNursing and Residential Care
Series BSep 11, 2025
Amount Raised: $7,664,247
Metagen Therapeutics

Tsuruoka, Yamagata, Japan

Metagen Therapeutics is a drug discovery and medical business company that utilizes microbiome science.

BiotechnologyClinical TrialsMedicalTherapeutics
Series BSep 8, 2025
Amount Raised: $15,690,352
RegCell

Osaka, Osaka, Japan

RegCell is a novel therapeutics company.

Alternative MedicineClinical TrialsOutpatient Care
SeedMar 18, 2025
Amount Raised: $8,500,000
Neusignal Therapeutics

Tokyo, Tokyo, Japan

Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Series AJan 31, 2025
Amount Raised: $7,409,553
Shinobi Therapeutics

South San Francisco, California, United States

Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.

BiotechnologyHealth CareTherapeutics
Series ADec 12, 2023
Amount Raised: $51,000,000
AIRNA

Cambridge, Massachusetts, United States

AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals.

BiotechnologyHealth CareMedical
Series ASep 19, 2023
Amount Raised: $30,000,000
Storm Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Targeting pathways that modify RNA to deliver novel cancer therapeutics

BiotechnologyHealth CareMedicalTherapeutics
Series BDec 14, 2022
Amount Raised: $30,000,000
LUCA Science

Tokyo, Tokyo, Japan

LUCA Science develops innovative treatments intended for mitochondrial and related diseases.

BiotechnologyHealth CarePharmaceutical
Series BJun 6, 2022
Amount Raised: $29,203,600
Celsius Therapeutics

Cambridge, Massachusetts, United States

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

BiotechnologyEmergency MedicineGeneticsHealth CarePrecision Medicine
Series BMar 24, 2022
Amount Raised: $83,000,000
Modulus Discovery

Tokyo, Tokyo, Japan

Modulus Discovery is a preclinical-stage technology-driven drug discovery firm.

BiotechnologyClinical TrialsMedicalNursing and Residential CarePharmaceutical
Series CMar 1, 2022
Amount Raised: $20,375,909